Paper12434014
Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
Sawkar AR and 5 others. Proc Natl Acad Sci U S A, 2002. Cited by 414 papers, by iCite.
Cite this record
ConductScience Library. Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease. Papers, record 12434014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12434014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 1-Deoxynojirimycin | Major topic |
| Gaucher Disease | Major topic |
| beta-Glucosidase | Major topic |
| Alkylation | |
| Amino Acid Substitution | |
| Cells, Cultured | |
| Dose-Response Relationship, Drug | |
| Endoplasmic Reticulum | |
| Fibroblasts | |
| Golgi Apparatus | |
| Heterocyclic Compounds | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Lysosomes | |
| Molecular Structure | |
| Morpholines | |
| Protein Denaturation | |
| Protein Folding | |
| Protein Transport | |
| Structure-Activity Relationship |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9883849 | Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. | Nat Med | 1999 | https://conductscience.org/library/papers/9883849 | PubMed |
| 2 | 8280613 | Gaucher disease mutations in non-Jewish patients. | Br J Haematol | 1993 | https://conductscience.org/library/papers/8280613 | PubMed |
| 3 | 8325864 | Human acid beta-glucosidase. N-glycosylation site occupancy and the effect of glycosylation on enzymatic activity. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8325864 | PubMed |
| 4 | 11927547 | Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. | EMBO J | 2002 | https://conductscience.org/library/papers/11927547 | PubMed |
| 5 | 10458780 | Carbohydrate Mimetics: A New Strategy for Tackling the Problem of Carbohydrate-Mediated Biological Recognition. | Angew Chem Int Ed Engl | 1999 | https://conductscience.org/library/papers/10458780 | PubMed |
| 6 | 11929328 | New prospects for the treatment of lysosomal storage diseases. | Drugs | 2002 | https://conductscience.org/library/papers/11929328 | PubMed |
| 7 | 1558964 | Mutations in Jewish patients with Gaucher disease. | Blood | 1992 | https://conductscience.org/library/papers/1558964 | PubMed |
| 8 | 5581982 | Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher's disease. | Am J Hum Genet | 1971 | https://conductscience.org/library/papers/5581982 | PubMed |
| 9 | 11221677 | Imino sugar therapy for type 1 Gaucher disease. | Glycobiology | 2000 | https://conductscience.org/library/papers/11221677 | PubMed |
| 10 | 12022475 | Gaucher disease: Perspectives on a prototype lysosomal disease. | Cell Mol Life Sci | 2002 | https://conductscience.org/library/papers/12022475 | PubMed |
| 11 | 9756888 | Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9756888 | PubMed |
| 12 | 10767320 | Structural features of normal and mutant human lysosomal glycoside hydrolases deduced from bioinformatics analysis. | Hum Mol Genet | 2000 | https://conductscience.org/library/papers/10767320 | PubMed |
| 13 | 10801168 | Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. | Lancet | 2000 | https://conductscience.org/library/papers/10801168 | PubMed |
| 14 | 10866822 | In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives. | Eur J Biochem | 2000 | https://conductscience.org/library/papers/10866822 | PubMed |
| 15 | 11121835 | Pharmacological chaperones: a new twist on receptor folding. | Trends Pharmacol Sci | 2000 | https://conductscience.org/library/papers/11121835 | PubMed |
| 16 | 8317294 | Gaucher disease. Enzymology, genetics, and treatment. | Adv Hum Genet | 1993 | https://conductscience.org/library/papers/8317294 | PubMed |
| 17 | 7831151 | Lysosomal storage diseases in adults. | Pathol Res Pract | 1994 | https://conductscience.org/library/papers/7831151 | PubMed |
| 18 | 3463977 | Glucocerebrosidase processing in normal fibroblasts and in fibroblasts from patients with type I, type II, and type III Gaucher disease. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3463977 | PubMed |
| 19 | 8647071 | Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. Predominant uptake by liver endothelial cells. | Eur J Biochem | 1996 | https://conductscience.org/library/papers/8647071 | PubMed |
| 20 | 8294487 | Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8294487 | PubMed |
Cited by163
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 414 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42889562 | A pH-Dependent Curcumin-Iminosugar Hybrid Promotes GCase Enhancement and Reactive Oxygen Species Reduction. | ACS Omega | 2026 | https://conductscience.org/library/papers/42889562 | PubMed |
| 41898609 | In Situ Differential Analysis of α- and β-Glycosidase Activities in Lysosomes After Internalization Using Glucosylcerebroside-Based Liposomes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898609 | PubMed |
| 41486281 | The role of ER-associated degradation and ER-phagy in health and disease. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41486281 | PubMed |
| 41465340 | Refining Mouse Models of Gaucher Disease: Advancing Mechanistic Insights, Biomarker Discovery, and Therapeutic Strategies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465340 | PubMed |
| 40553789 | Unifying perspectives on the activity and genotypic targeting of pharmacological chaperones. | J Biol Chem | 2025 | https://conductscience.org/library/papers/40553789 | PubMed |
| 40362629 | Allosteric Modulation of GCase Enhances Lysosomal Activity and Reduces ER Stress in GCase-Related Disorders. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362629 | PubMed |
| 39735330 | Current opinion on pluripotent stem cell technology in Gaucher's disease: challenges and future prospects. | Cytotechnology | 2025 | https://conductscience.org/library/papers/39735330 | PubMed |
| 39404383 | Functional Analysis of Human GBA1 Missense Mutations in Drosophila: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences. | Cells | 2024 | https://conductscience.org/library/papers/39404383 | PubMed |
| 39388267 | High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson's disease. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39388267 | PubMed |
| 39188936 | Endoplasmic reticulum stress in diseases. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39188936 | PubMed |
| 39150784 | A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39150784 | PubMed |
| 38643239 | A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease. | Commun Chem | 2024 | https://conductscience.org/library/papers/38643239 | PubMed |
| 38559739 | Mechanistic Insights into Dibasic Iminosugars as pH-Selective Pharmacological Chaperones to Stabilize Human α-Galactosidase. | JACS Au | 2024 | https://conductscience.org/library/papers/38559739 | PubMed |
| 37627292 | Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification. | Biomolecules | 2023 | https://conductscience.org/library/papers/37627292 | PubMed |
| 37407509 | CpxA/R-Controlled Nitroreductase Expression as Target for Combinatorial Therapy against Uropathogens by Promoting Reactive Oxygen Species Generation. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37407509 | PubMed |
| 36907956 | SMPD1 expression profile and mutation landscape help decipher genotype-phenotype association and precision diagnosis for acid sphingomyelinase deficiency. | Hereditas | 2023 | https://conductscience.org/library/papers/36907956 | PubMed |
| 36291241 | Precision Medicine in Parkinson's Disease: From Genetic Risk Signals to Personalized Therapy. | Brain Sci | 2022 | https://conductscience.org/library/papers/36291241 | PubMed |
| 35890122 | GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35890122 | PubMed |
| 35704026 | Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT. | J Exp Med | 2022 | https://conductscience.org/library/papers/35704026 | PubMed |
| 35606425 | Repurposing drugs to treat cardiovascular disease in the era of precision medicine. | Nat Rev Cardiol | 2022 | https://conductscience.org/library/papers/35606425 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GBA1 | 2629 | PubTator's text mining | https://conductscience.org/library/genes/2629 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12434014
GET https://conductscience.org/api/papers/v1/12434014/references?page=2